发明名称 2-(substituert-amino)-benzoxasolsulfonamid med HIV proteasehemmende virkning
摘要 The present invention concerns the compounds having the formula N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein R<SUB>1 </SUB>and R<SUB>8 </SUB>each are H, optionally substituted C<SUB>1-6</SUB>alkyl, C<SUB>2-6</SUB>alkenyl, C<SUB>3-7</SUB>cycloalkyl, aryl, Het<SUP>1</SUP>, Het<SUP>2</SUP>; R<SUB>1 </SUB>may also be a radical of formula (R<SUB>11a</SUB>R<SUB>11b</SUB>)NC(R<SUB>10a</SUB>R<SUB>10b</SUB>)CR<SUB>9</SUB>-; t is 0, 1 or 2; R<SUB>2 </SUB>is H or C<SUB>1-6</SUB>alkyl; L is -C(-O)-, -O-C(-O)-, -NR<SUB>8</SUB>-C(-O)-, -O-C<SUB>1-6</SUB>alkanediyl-C(-O)-, -NR<SUB>8</SUB>-C<SUB>1-6</SUB>alkanediyl-C(-O)-, -S(-O)<SUB>2</SUB>-, -O-S(-O)<SUB>2</SUB>-, -NR<SUB>8</SUB>-S(-O)<SUB>2</SUB>; R<SUB>3 </SUB>is C<SUB>1-6</SUB>alkyl, aryl, C<SUB>3-7</SUB>cycloalkyl, C<SUB>3-7</SUB>cycloalkylC<SUB>1-4</SUB>alkyl, or arylC<SUB>1-4</SUB>alkyl; R<SUB>4 </SUB>is H, C<SUB>1-4</SUB>alkylOC(-O), carboxyl, aminoC(-O), mono- or di(C<SUB>1-4</SUB>alkyl)aminoC(-O), C<SUB>3-7</SUB>cycloalkyl, C<SUB>2-6</SUB>alkenyl, C<SUB>2-6</SUB>alkynyl or optionally substituted C<SUB>1-6</SUB>alkyl; A is C<SUB>1-6</SUB>alkanediyl, -C(-O)-, -C(-S)-, -S(-O)<SUB>2</SUB>-, C<SUB>1-6</SUB>alkanediyl-C(-O)-, C<SUB>1-6</SUB>alkanediyl-C(-S)- or C<SUB>1-6</SUB>alkanediyl-S(-O)<SUB>2</SUB>-; R<SUB>5 </SUB>is H, OH, C<SUB>1-6</SUB>alkyl, Het<SUP>1</SUP>C<SUB>1-6</SUB>alkyl, Het<SUP>2</SUP>C<SUB>1-6</SUB>alkyl, optionally substituted aminoC<SUB>1-6</SUB>alkyl; R<SUB>6 </SUB>is C<SUB>1-6</SUB>alkylO, Het<SUP>1</SUP>, Het<SUP>1</SUP>O, Het<SUP>2</SUP>, Het<SUP>2</SUP>O, aryl, arylO, C<SUB>1-6</SUB>alkyloxycarbonylamino or amino; and in case -A- is other than C<SUB>1-6</SUB>alkanediyl then R<SUB>6 </SUB>may also be C<SUB>1-6</SUB>alkyl, Het<SUP>1</SUP>C<SUB>1-4</SUB>alkyl, Het<SUP>1</SUP>OC<SUB>1-4</SUB>alkyl, Het<SUP>2</SUP>C<SUB>1-4</SUB>alkyl, Het<SUP>2</SUP>OC<SUB>1-4</SUB>alkyl, arylC<SUB>1-4</SUB>alkyl, arylOC<SUB>1-4</SUB>alkyl or aminoC<SUB>1-4</SUB>alkyl; whereby each of the amino groups in the definition of R<SUB>6 </SUB>may optionally be substituted; -A-R<SUB>6 </SUB>is hydroxyC<SUB>1-6</SUB>alkyl; R<SUB>5 </SUB>and -A-R<SUB>6 </SUB>taken together with the nitrogen atom to which they are attached may also form Het<SUP>1 </SUP>or Het<SUP>2</SUP>. It further relates to their use as broadspectrum HIV protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. It also concerns combinations thereof with another anti-retroviral agent, and to their use in assays as reference compounds or as reagents.
申请公布号 NO328896(B1) 申请公布日期 2010.06.07
申请号 NO20030004505 申请日期 2003.10.08
申请人 TIBOTEC PHARMACEUTICALS LTD 发明人 VERSCHUEREN WIM GASTON;VENDEVILLE SANDRINE MARIE HELENE;BETHUNE MARIE-PIERRE T M M G DE;KOCK HERMAN AUGUSTINUS DE;TAHRI ABDELLAH;SOLA MONTSERRAT ERRA;SURLERAUX DOMINIQUE LOUIS NESTOR GHISLAIN
分类号 C07D493/04;A61K31/423;A61K31/427;A61K31/4439;A61K31/454;A61K31/496;A61P31/18;A61P35/00;A61P43/00;C07D263/58;C07D413/04;C07D417/12;C07D417/14 主分类号 C07D493/04
代理机构 代理人
主权项
地址